This is a Study to Assess the Safety and Immunogenicity of Ixiaro® (IC51) in an Elderly Population

Clinical trial NCT01158599 · COMPLETED

Trial details

NCT number: NCT01158599
Sponsor: Valneva Austria GmbH
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Japanese Encephalitis

Start date: 2010-06-01
Primary completion: 2011-06-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.